#bronchiectasis #respiratory #CHMP #Insmed #brensocatib #Brinsupri #noncysticfibrosisbronchiectasis #NCFB #ASPENtrial #Sanofi #Wayrilz #rilzabrutinib #immunethrombocytopenia #ITP #SanofiWinthrop #Rezurock #belumosudil #chronicgraftversushostdisease #GvHD #transplant #KadmonPharma
zurl.co/r27x2
zurl.co/r27x2
CHMP backs first drug for lung disease bronchiectasis
Insmed gets EU recommendation for first non-cystic fibrosis bronchiectasis therapy Brinsupri, and other CHMP decisions.
zurl.co
October 21, 2025 at 10:11 AM
Chronic GVHD affects 92% of skin and 78% of oral tissues in HCT survivors. A new Nature Rev…
#Chronicgraftversushostdisease #Haematopoieticcelltransplantation #Immunosuppression #JAKinhibitors #Transplantcomplications
#Chronicgraftversushostdisease #Haematopoieticcelltransplantation #Immunosupp…
#Chronicgraftversushostdisease #Haematopoieticcelltransplantation #Immunosuppression #JAKinhibitors #Transplantcomplications
#Chronicgraftversushostdisease #Haematopoieticcelltransplantation #Immunosupp…
Chronic GVHD: Diagnosis & Multidisciplinary Management
Chronic GVHD affects 92% of skin and 78% of oral tissues in HCT survivors. A new Nature Rev…
#Chronicgraftversushostdisease #Haematopoieticcelltransplantation #Immunosuppression #JAKinhibitors #Transplantcomplications
news.gmj.ge
July 10, 2026 at 7:52 PM
Chronic GVHD affects 92% of skin and 78% of oral tissues in HCT survivors. A new Nature Rev…
#Chronicgraftversushostdisease #Haematopoieticcelltransplantation #Immunosuppression #JAKinhibitors #Transplantcomplications
#Chronicgraftversushostdisease #Haematopoieticcelltransplantation #Immunosupp…
#Chronicgraftversushostdisease #Haematopoieticcelltransplantation #Immunosuppression #JAKinhibitors #Transplantcomplications
#Chronicgraftversushostdisease #Haematopoieticcelltransplantation #Immunosupp…